KR20160081964A - 결정성 베타-락타마아제 억제제 - Google Patents

결정성 베타-락타마아제 억제제 Download PDF

Info

Publication number
KR20160081964A
KR20160081964A KR1020167014701A KR20167014701A KR20160081964A KR 20160081964 A KR20160081964 A KR 20160081964A KR 1020167014701 A KR1020167014701 A KR 1020167014701A KR 20167014701 A KR20167014701 A KR 20167014701A KR 20160081964 A KR20160081964 A KR 20160081964A
Authority
KR
South Korea
Prior art keywords
methyl
formula
crystalline compound
peaks
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020167014701A
Other languages
English (en)
Korean (ko)
Inventor
알레산드로 라모니카
마르코 포르자띠
스테파노 비온디
Original Assignee
알레크라 테라퓨틱스 에스에이에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49818360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20160081964(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 알레크라 테라퓨틱스 에스에이에스 filed Critical 알레크라 테라퓨틱스 에스에이에스
Publication of KR20160081964A publication Critical patent/KR20160081964A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/87—Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020167014701A 2013-11-08 2014-11-07 결정성 베타-락타마아제 억제제 Withdrawn KR20160081964A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1319776.9A GB201319776D0 (en) 2013-11-08 2013-11-08 Compound
GB1319776.9 2013-11-08
GBGB1408643.3A GB201408643D0 (en) 2013-11-08 2014-05-15 Compound
GB1408643.3 2014-05-15
PCT/EP2014/074108 WO2015067787A1 (en) 2013-11-08 2014-11-07 Crystalline beta-lactamase inhibitor

Publications (1)

Publication Number Publication Date
KR20160081964A true KR20160081964A (ko) 2016-07-08

Family

ID=49818360

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167014701A Withdrawn KR20160081964A (ko) 2013-11-08 2014-11-07 결정성 베타-락타마아제 억제제

Country Status (14)

Country Link
US (2) US20160289245A1 (enExample)
EP (1) EP3066103A1 (enExample)
JP (2) JP7045795B2 (enExample)
KR (1) KR20160081964A (enExample)
CN (1) CN105873935B (enExample)
AU (1) AU2014345507B2 (enExample)
CA (1) CA2929199C (enExample)
CL (1) CL2016001097A1 (enExample)
EA (1) EA031348B1 (enExample)
GB (2) GB201319776D0 (enExample)
IL (1) IL245386A0 (enExample)
MX (1) MX2016005869A (enExample)
PE (1) PE20160890A1 (enExample)
WO (1) WO2015067787A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound
WO2026086730A1 (zh) * 2024-10-21 2026-04-30 齐鲁制药有限公司 恩美他唑巴坦的晶型及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US6156745A (en) * 1997-12-29 2000-12-05 Research Corporation Technologies, Inc. 2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
US7273935B2 (en) * 2003-08-21 2007-09-25 Orchid Chemicals & Pharmaceuticals, Ltd. Process for the preparation of 3-methylcepham derivatives
US7417143B2 (en) * 2004-04-07 2008-08-26 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of Tazobactam in pure form
US7687488B2 (en) * 2006-07-12 2010-03-30 Orchid Chemicals & Pharmaceuticals Ltd. 2-substituted methyl penam derivatives
NZ610247A (en) * 2010-11-25 2014-09-26 Allecra Therapeutics Gmbh Β-lactamase inhibitors and their use
EP2847205A4 (en) * 2012-05-07 2016-01-20 Univ California NOVEL OXYSTEROL ANALOGUE OXY149 FOR THE INDUCTION OF OSTEOGENESIS AND HEDGEHOG SIGNAL PATH AND THE INHIBITION OF ADIPOGENESIS
US9683009B2 (en) * 2013-05-02 2017-06-20 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents
GB201319776D0 (en) 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound
GB201408649D0 (en) * 2014-05-15 2014-07-02 Allecra Therapeutics Sas Method
KR20170101940A (ko) * 2014-12-09 2017-09-06 워쏘우 오르쏘페딕 인코포레이티드 스테롤 관련 화합물 및 방법

Also Published As

Publication number Publication date
EP3066103A1 (en) 2016-09-14
GB201319776D0 (en) 2013-12-25
CA2929199A1 (en) 2015-05-14
GB201408643D0 (en) 2014-07-02
US20190071456A1 (en) 2019-03-07
JP7045795B2 (ja) 2022-04-01
CN105873935B (zh) 2019-03-19
CA2929199C (en) 2023-01-03
CL2016001097A1 (es) 2016-12-02
AU2014345507A1 (en) 2016-05-19
WO2015067787A1 (en) 2015-05-14
JP2016535054A (ja) 2016-11-10
US20160289245A1 (en) 2016-10-06
AU2014345507B2 (en) 2018-11-22
JP2021102642A (ja) 2021-07-15
EA031348B1 (ru) 2018-12-28
JP7346485B2 (ja) 2023-09-19
PE20160890A1 (es) 2016-08-25
CN105873935A (zh) 2016-08-17
MX2016005869A (es) 2017-01-05
US11124526B2 (en) 2021-09-21
IL245386A0 (en) 2016-06-30
EA201690963A1 (ru) 2016-10-31

Similar Documents

Publication Publication Date Title
JP2011506374A (ja) テノホビルジソプロキシルの固形物
MX2011010657A (es) Proceso para la preparacion de sales de pirrolidinio.
TW201629062A (zh) 二氮雜雙環辛烷衍生物之結晶及安定的凍結乾燥製劑的製造法
US20170334860A1 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
JP7346485B2 (ja) 結晶性β－ラクタマーゼ阻害剤
WO2020049598A2 (en) Apalutamide polymorphs
WO2011097958A1 (zh) 含有氨基磺酰基氮杂环丁烷基的口服碳青霉烯化合物
JP4130078B2 (ja) カルバペネム誘導体結晶と注射製剤
KR20040075857A (ko) 결정질 및 비결정질 무피로신 칼슘의 제조 방법
JPWO2000075143A1 (ja) カルバペネム誘導体結晶と注射製剤
KR20150042275A (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
CN102361850A (zh) 分离替加环素的方法
US20220009929A1 (en) Polymorphic forms of ibrutinib
JP2954956B2 (ja) 結晶（５ｒ，６ｓ）‐２‐カルバモイルオキシメチル‐６‐［（１ｒ）‐ヒドロキシエチル］‐２‐ペネム‐カルボン酸及びその医薬処方物
KR101561963B1 (ko) 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
BR112016010282B1 (pt) Composição farmacêutica compreendendo um inibidor de betalactamase cristalino
US20080227768A1 (en) Crystal of 1-Methylcarbapenem Compound
WO2006109324A2 (en) Processes for preparation of amorphous cefepime acid addition salts
WO2013132422A1 (en) An improved process for the preparation of carbapenem antibiotic
EP3441395A1 (en) Method for preparing penams
JP2010013356A (ja) 結晶性カルバペネム化合物
KR20100125124A (ko) 피타바스타틴 헤미칼슘염의 신규한 결정형 및 그의 제조방법
JPH0720971B2 (ja) 結晶性アモキシシリンナトリウム，その製法及びそれを含む医薬組成物
KR20100098439A (ko) β-락탐 화합물의 안정형 결정
HK1167647A1 (en) 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000